The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials
Open accessAbstract
Disease-free survival is increasingly being used as the primary endpoint of most trials testing adjuvant treatments in cancer. Other frequently used endpoints include overall survival, recurrence-free survival, and time to recurrence. These endpoints are often defined differently in different trials in the same type of cancer, leading to a lack of comparability among trials. In this Commentary, we used adjuvant studies in colon cancer as a model to address this issue. In a systematic review of the literature, we identified 52 studies of adjuvant treatment in colon cancer published in 1997-2006 that used eight other endpoints in addition to overall survival. Both the definition of these endpoints and the starting point for measuring time to the events that constituted these endpoints varied widely. A panel of experts on clinical research on colorectal cancer then reached consensus on the definition of each endpoint. Disease-free survival--defined as the time from randomization to any event, irrespective of cause--was considered to be the most informative endpoint for assessing the effect of treatment and therefore the most relevant to clinical practice. The proposed guidelines may add to the quality and cross-comparability of future studies of adjuvant treatments for cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Capecitabine as Adjuvant Treatment for Stage III Colon Cancer
Twelves, C., Wong, A., Nowacki, M. P., Abt, M., Burris, H., Carrato, A., Cassidy, J., Cervantes, A., Fagerberg, J., Georgoulias, V., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043116 · Cited by 1,248
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-5-199503010-00001 · Cited by 925
European Organization for Research and Treatment of Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/ykqg4k · Cited by 756
Sargent, D. J., Wieand, H. S., Haller, D. G., Gray, R., Benedetti, J. K., Buyse, M., Labianca, R., Seitz, J. F., O'Callaghan, C. J., Francini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6071 · Cited by 713
O'Connell, M. J., Mailliard, J. A., Kahn, M. J., Macdonald, J. S., Haller, D. G., Mayer, R. J., & Wieand, H. S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.246 · Cited by 585
Riethmüller, G., Holz, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Funke, I., Pichlmaier, H., Hirche, H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1788 · Cited by 517
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
Vermorken, J. B., Claessen, A. M., van Tinteren, H., Gall, H. E., Ezinga, R., Meijer, S., Scheper, R. J., Meijer, C. J., Bloemena, E., Ransom, J. H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07186-4 · Cited by 504
Wolmark, N., Rockette, H., Mamounas, E., Jones, J., Wieand, S., Wickerham, D. L., Bear, H. D., Atkins, J. N., Dimitrov, N. V., Glass, A. G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3553 · Cited by 493
Haller, D. G., Catalano, P. J., Macdonald, J. S., O'Rourke, M. A., Frontiera, M. S., Jackson, D. V., & Mayer, R. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5686 · Cited by 391
Lembersky, B. C., Wieand, H. S., Petrelli, N. J., O'Connell, M. J., Colangelo, L. H., Smith, R. E., Seay, T. E., Giguere, J. K., Marshall, M. E., Jacobs, A. D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7498 · Cited by 328
Harris, J. E., Ryan, L., Hoover, H. C., Stuart, R. K., Oken, M. M., Benson, A. B., Mansour, E., Haller, D. G., Manola, J., & Hanna, M. G. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.148 · Cited by 273
André, T., Colin, P., Louvet, C., Gamelin, E., Bouche, O., Achille, E., Colbert, N., Boaziz, C., Piedbois, P., Tubiana-Mathieu, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.065 · Cited by 262
Self-citationBarr, E., & Koutsky, L. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh071 · Cited by 230
Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III
on behalf of the NACCP group*, Taal, B. G., Van Tinteren, H., & Zoetmulder, F. A. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2117 · Cited by 218
Punt, C. J., Nagy, A., Douillard, J.-Y., Figer, A., Skovsgaard, T., Monson, J., Barone, C., Fountzilas, G., Riess, H., Moylan, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09836-7 · Cited by 213
Self-citationWolmark, N., Wieand, S., Kuebler, J. P., Colangelo, L., & Smith, R. E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba3500 · Cited by 176
Cutsem, E. V., Labianca, R., Hossfeld, D., Bodoky, G., Roth, A. D., Aranda, E., Nordlinger, B., Assadourian, S., Wang, K., & Cunningham, D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba8 · Cited by 130
Self-citationOhwada, S., IKEYA, T., Yokomori, T., Kusaba, T., Roppongi, T., Takahashi, T., Nakamura, S., Kakinuma, S., Iwazaki, S., Ishikawa, H., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601619 · Cited by 118
Wolmark, N., Smith, R. P., Fisher, B., Bryant, J., Hyams, D. M., Atkins, J., Dimitrov, N. S., Oishi, R. H., Prager, D., Fehrenbacher, L., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1810 · Cited by 101
Scheithauer, W., Kornek, G. V., Marczell, A. P., Karner, J., Salem, G., Greiner, R., Bürger, D., Stöger, F. X., Ritschel, J., Kovats, E., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.225 · Cited by 93
Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial
Rougier, P. R., Sahmoud, T., Nitti, D., Curran, D., Doci, R., Waele, B. D., Nakajima, T., Rauschecker, H., Labianca, R., Pector, J., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08169-5 · Cited by 84
Self-citationRandomized Trial of Adjuvant Therapy in Colon Carcinoma: 10-Year Results of NSABP Protocol C-01
Smith, R. E., Colangelo, L. H., Wieand, H. S., Begovič, M., & Wolmark, N. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh220 · Cited by 83
Kato, T., Ohashi, Y., Nakazato, H., Koike, A., Saji, S., Suzuki, H., Takagi, H., Nimura, Y., Hasumi, A., Baba, S., et al. (2002) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-002-0278-x · Cited by 71
Hartung, G., Hofheinz, R. D., Dencausse, Y., Sturm, J., Kopp‐Schneider, A., Dietrich, G., Fackler-Schwalbe, I., Bornbusch, D., Gonnermann, M., Wojatschek, C., et al. (2005) · Oncology Research and Treatment · doi:10.1159/000084595 · Cited by 71
Ito, K., Nakazato, H., Koike, A., Takagi, H., Saji, S., Baba, S., Mai, M., Sakamoto, J., & Ohashi, Y. (2004) · International Journal of Colorectal Disease · doi:10.1007/s00384-003-0532-x · Cited by 52
Nitti, D., Wils, J. A., Sahmoud, T., Curran, D., Couvreur, M. L., Lise, M., Rauschecker, H., dos Santos, J. G., Stremmel, W., & Roelofsen, F. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00052-x · Cited by 43
Sadahiro, S., Suzuki, T., Ishikawa, K., Yasuda, S., Tajima, T., Makuuchi, H., Saitoh, T., & Murayama, C. (2004) · Cancer · doi:10.1002/cncr.11945 · Cited by 42
Definition of disease-free survival: this is my truth–show me yours
Chua, Y. J., Sargent, D. J., & Cunningham, D. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi373 · Cited by 33
for the Austrian Breast and Colorectal Cancer Study Group, Schippinger, W., Jagoditsch, M., Sorre, C., Gnant, M., Steger, G. G., Hausmaninger, H., Mlineritsch, B., Schaberl-Moser, R., Mischinger, H. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602555 · Cited by 30
collaborators, T. A. (2003) · British journal of surgery · doi:10.1002/bjs.4266 · Cited by 30
Costanzo, F. D., Sobrero, A. F., Gasperoni, S., Dogliotti, L., Frassineti, G. L., Falcone, A., Lionetto, R., Bruzzi, P., Luppi, G., Gallo, L., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg359 · Cited by 28
Self-citationBleeker, W. A., Mulder, N. H., Hermans, J., Otter, R., & Plukker, J. T. M. (2000) · Annals of Oncology · doi:10.1023/a:1008351312879 · Cited by 24
Cascinu, S., Catalano, V., Piga, A., Mattioli, R., Marcellini, M., Pancotti, A., Bascioni, R., Torresi, U., Silva, R. R., Pieroni, V., et al. (2003) · Cancer Investigation · doi:10.1081/cnv-120023769 · Cited by 20
Adjuvant chemotherapy for colon cancer: a confusing area!
Douillard, J., & Bennouna, J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi413 · Cited by 13
Self-citationNakagoe, T., Ishikawa, H., Sawai, T., et al. (2000) · PubMed · Cited by 7
Cited by
Liu, J., Lichtenberg, T., Hoadley, K. A., Poisson, L. M., Lazar, A. J., Cherniack, A. D., Kovatich, A. J., Benz, C. C., Levine, D. A., Lee, A. V., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.052 · Cited by 3,725
5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs
Chen, X., Li, A., Sun, B.-F., Yang, Y., Han, Y.-N., Yuan, X., Chen, R.-X., Wei, W.-S., Liu, Y., Gao, C.-C., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0361-y · Cited by 801
Standardising outcomes for clinical trials and systematic reviews
Clarke, M. (2007) · Trials · doi:10.1186/1745-6215-8-39 · Cited by 483
Janda, M., Gebski, V., Davies, L. C., Forder, P., Brand, A., Hogg, R., Jobling, T. W., Land, R., Manolitsas, T., Nascimento, M., et al. (2017) · JAMA · doi:10.1001/jama.2017.2068 · Cited by 447
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
Courneya, K. S., Vardy, J. L., O’Callaghan, C. J., Gill, S., Friedenreich, C. M., Wong, R. K. S., Dhillon, H. M., Coyle, V., Chua, N. S., Jonker, D. J., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2502760 · Cited by 415
Metadata
- Authors
- Punt, C. J. A., Buyse, M., Kohne, C.-H., Hohenberger, P., Labianca, R., Schmoll, H. J., Pahlman, L., Sobrero, A., & Douillard, J.-Y.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-27
- Volume
- 99
- Issue
- 13
- Pages
- 998-1003
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2143396070
- Cited by
- 379
- References
- 38
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.